Management of community-acquired pneumonia in older adults

Therapeutic Advances in Infectious Disease

Volumn 2, Issue 1, 2014, Pages 3-16

  Simonetti, Antonella F ^a   Viasus, Diego ^a   Garcia Vidal, Carolina ^b   Carratal, Jordi ^b  

^a Hospital Universitari de Bellvitge IDIBELL   (Colombia)

^b Department of Infectious Diseases   (Colombia)

Author keywords

clinical features; community acquired pneumonia; elderly; etiology; management; prognosis; treatment

Indexed keywords

EID: 84993767761     PISSN: 20499361     EISSN: 2049937X     Source Type: Journal    
DOI: 10.1177/2049936113518041     Document Type: Review

References (82)

1. Abisheganaden J. Ding Y. Chong W. Heng B. Lim T. (2012) Predicting mortality among older adults hospitalized for community-acquired pneumonia: an enhanced confusion, urea, respiratory rate and blood pressure score compared with pneumonia severity index. Respirology 17: 969–975.
2. Ahkee S. Srinath L. Ramirez J. (1997) Community-acquired pneumonia in the elderly: association of mortality with lack of fever and leukocytosis. South Med J 90: 296–298.
3. Almirall J. Rofes L. Serra-Prat M. Icart R. Palomera E. Arreola V. et al (2013) Oropharyngeal dysphagia is a risk factor for community-acquired pneumonia in the elderly. Eur Respir J 41: 923–928.
4. Arnold F. LaJoie A. Brock G. Peyrani P. Rello J. Menéndez R. et al (2009) Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results. Arch Intern Med 169: 1515–1524.
5. Bolotin S. Pebody R. White P. McMenamin J. Perera L. Nguyen-Van-Tam J. et al (2012) A new sentinel surveillance system for severe influenza in England shows a shift in age distribution of hospitalised cases in the post-pandemic period. PloS ONE 7: e30279–e30279.
6. Bont J. Hak E. Hoes A. Macfarlane J. Verheij T. (2008) Predicting death in elderly patients with community-acquired pneumonia: a prospective validation study reevaluating the CRB-65 severity assessment tool. Arch Intern Med 168: 1465–1468.
7. Brito V. Niederman M. (2010) Predicting mortality in the elderly with community-acquired pneumonia: should we design a new car or set a new ‘speed limit’? Thorax 65: 944–945.
8. Carratalà J. Garcia-Vidal C. Ortega L. Fernández-Sabé N. Clemente M. Albero G. et al (2012) Effect of a 3-step critical pathway to reduce duration of intravenous antibiotic therapy and length of stay in community-acquired pneumonia: a randomized controlled trial. Arch Intern Med 172: 922–928.
9. Carratalà J. Mykietiuk A. Fernández-Sabé N. Suárez C. Dorca J. Verdaguer R. et al (2007) Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes. Arch Intern Med 167: 1393–1399.
10. Centers for Disease Control and Prevention (2003) Trends in aging - United States and worldwide. MMWR Morb Mortal Wkly Rep 52: 101–106.
11. Chen J. Chang S. Liu J. Chan R. Wu J. Wang W. et al (2010) Comparison of clinical characteristics and performance of pneumonia severity score and CURB-65 among younger adults, elderly and very old subjects. Thorax 65: 971–977.
12. Chowell G. Bertozzi S. Colchero M. Lopez-Gatell H. Alpuche-Aranda C. Hernandez M. et al (2009) Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med 361: 674–679.
13. Conte H. Chen Y. Mehal W. Scinto J. Quagliarello V. (1999) A prognostic rule for elderly patients admitted with community-acquired pneumonia. Am J Med 106: 20–28.
14. Domínguez A. Izquierdo C. Salleras L. Ruiz L. Sousa D. Bayas J. et al (2010) Effectiveness of the pneumococcal polysaccharide vaccine in preventing pneumonia in the elderly. Eur Respir J 36: 608–614.
15. Donowitz G. Cox H. (2007) Bacterial community-acquired pneumonia in older patients. Clin Geriatr Med 23: 515–534.
16. El-Solh A. Sikka P. Ramadan F. Davies J. (2001) Etiology of severe pneumonia in the very elderly. Am J Respir Crit Care Med 163: 645–651.
17. El Solh A. Pineda L. Bouquin P. Mankowski C. (2006) Determinants of short and long term functional recovery after hospitalization for community-acquired pneumonia in the elderly: role of inflammatory markers. BMC Geriatr 6: 12–13.
18. European Centre for Disease Prevention and Control (2005–2013) European Antimicrobial Resistance Surveillance Network. Available at: http://www.ecdc.europa.eu/en/healthtopics/antimicrobial_resistance/database/Pages/map_reports.aspx.
19. Ewig S. Kleinfeld T. Bauer T. Seifert K. Schäfer H. Göke N. (1999) Comparative validation of prognostic rules for community acquired pneumonia in an elderly population. Eur Respir J 14: 370–375.
20. Ewig S. Welte T. Chastre J. Torres A. (2010) Rethinking the concepts of community-acquired and health-care-associated pneumonia. Lancet Infect Dis 10: 279–287.
21. Farr B. Bartlett C. Wadsworth J. Miller D. (2000) Risk factors for community-acquired pneumonia diagnosed upon hospital admission. British Thoracic Society Pneumonia Study Group. Respir Med 94: 954–963.
22. Fernández-Sabé N. Carratalà J. Rosón B. Dorca J. Verdaguer R. Manresa F. et al (2003) Community-acquired pneumonia in very elderly patients: causative organisms, clinical characteristics, and outcomes. Medicine (Baltimore) 82: 159–169.
23. Fine M. Auble T. Yealy D. Hanusa B. Weissfeld L. Singer D. et al (1997) A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336: 243–250.
24. Fung H. Monteagudo-Chu M. (2010) Community-acquired pneumonia in the elderly. Am J Geriatr Pharmacother 8: 47–62.
25. García-Ordóñez M. García-Jiménez J. Páez F. Alvarez F. Poyato B. Franquelo M. et al (2001) Clinical aspects and prognostic factors in elderly patients hospitalised for community-acquired pneumonia. Eur J Clin Microbiol Infect Dis 20: 14–19.
26. Ho J. Chan K. Hu W. Lam W. Zheng L. Tipoe G. et al (2001) The effect of aging on nasal mucociliary clearance, beat frequency, and ultrastructure of respiratory cilia. Am J Respir Crit Care Med 163: 983–988.
27. Huss A. Scott P. Stuck A. Trotter C. Egger M. (2009) Efficacy of pneumococcal vaccination in adults: a meta-analysis. CMAJ 180: 48–58.
28. Jackson M. Nelson J. Jackson L. (2009) Risk factors for community-acquired pneumonia in immunocompetent seniors. J Am Geriatr Soc 57: 882–888.
29. Jackson L. Gurtman A. Rice K. Pauksens K. Greenberg R. Jones T. et al (2013) Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine. Vaccine 31: 3585–3593.
30. Janssens J. Gauthey L. Herrmann F. Tkatch L. Michel J. (1996) Community-acquired pneumonia in older patients. J Am Geriatr Soc 44: 539–544.
31. Janssens P. Krause K. (2004) Pneumonia in the very old. Lancet Infect Dis 4: 112–124.
32. Jefferson T. Di Pietrantonj C. Rivetti A. Bawazeer G. Al-Ansary L. Ferroni E. (2010) Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 7: CD001269–CD001269.
33. Jones R. Sader H. Moet G. Farrell D. (2010) Declining antimicrobial susceptibility of Streptococcus pneumoniae in the United States: report from the SENTRY Antimicrobial Surveillance Program (1998–2009). Diagn Microbiol Infect Dis 68: 334–336.
34. Juthani-Mehta M. de Rekeneire N. Allore H. Chen S. O'Leary J. Bauer D. et al (2013) Modifiable risk factors for pneumonia requiring hospitalization of community-dwelling older adults: The Health, Aging, and Body Composition Study. JAGS 61: 1111–1118.
35. Kaplan V. Angus D. Griffin M. Clermont G. Scott Watson R. Linde-Zwirble W. (2002) Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States. Am J Respir Crit Care Med 165: 766–772.
36. Keipp Talbo H. Falsey A. (2010) The diagnosis of viral respiratory disease in older adults. Clin Infect Dis 50: 747–751.
37. Kelly E. MacRedmond R. Cullen G. Greene C. McElvaney N. O'Neill S. (2009) Community-acquired pneumonia in older patients: does age influence systemic cytokine levels in community-acquired pneumonia? Respirology 14: 210–216.
38. Kikuchi R. Watabe N. Konno T. Mishina N. Sekizawa K. Sasaki H. (1994) High incidence of silent aspiration in elderly patients with community-acquired pneumonia. Am J Respir Crit Care Med 150: 251–253.
39. Kim J. Seo J. Mok J. Kim M. Cho W. Lee K. et al (2013) Usefulness of plasma procalcitonin to predict severity in elderly patients with community-acquired pneumonia. Tuberc Respir Dis 74: 207–214.
40. Klausen H. Petersen J. Lindhardt T. Bandholm T. Hendriksen C. Kehlet H. et al (2012) Outcomes in elderly Danish citizens admitted with community-acquired pneumonia. Regional differences, in a public healthcare system. Respir Med 106: 1778–1787.
41. Kothe H. Bauer T. Marre R. Suttorp N. Welte T. Dalhoff K. (2008) Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment. Eur Respir J 32: 139–146.
42. Lamontagne F. Garant M. Carvalho J. Lanthier L. Smieja M. Pilon D. (2008) Pneumococcal vaccination and risk of myocardial infarction. CMAJ 179: 773–777.
43. Lim W. Macfarlane J. (2001) Defining prognostic factors in the elderly with community acquired pneumonia: a case controlled study of patients aged ≥75 yrs. Eur Respir J 17: 200–205.
44. Lim W. van der Eerden M. Laing R. Boersma W. Karalus N. Town G. et al (2003) Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 58: 377–382.
45. Lindhardt T. Klausen H. Christiansen C. Smith L. Pedersen J. Andersen O. (2013) Elderly patients with community-acquired pneumonia are not treated according to current guidelines. Dan Med J 60: A4572–A4572.
46. Ma H. Tang W. Woo J. (2011) Predictors of in-hospital mortality of older patients admitted for community-acquired pneumonia. Age Ageing 40: 736–741.
47. Mandell L. Wunderink R. Anzueto A. Bartlett J. Campbell G. Dean N. et al (2007) Infectious Diseases Society of America / American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44(Suppl. 2): S27–S72.
48. Marik P. (2001) Aspiration pneumonitis and aspiration pneumonia. N Engl J Med 344: 665–671.
49. Marik P. Kaplan D. (2003) Aspiration pneumonia and dysphagia in the elderly. Chest 124: 328–336.
50. Maruyama T. Taguchi O. Niederman M. Morser J. Kobayashi H. Kobayashi T. et al (2010) Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial. BMJ 340: c1004–c1004.
51. May D. Kelly J. Mendlein J. Garbe P. (1991) Surveillance of major causes of hospitalization among the elderly, 1988. MMWR Morb Mortal Wkly Rep 40: 7–21.
52. Metlay J. Schulz R. Li Y. Singer D. Marrie T. Coley C. et al (1997) Influence of age on symptoms at presentation in patients with community-acquired pneumonia. Arch Intern Med 157: 1453–1459.
53. Meyer K. (2001) The role of immunity in susceptibility to respiratory infection in the aging lung. Respir Physiol 128: 23–31.
54. Moberley S. Holden J. Tatham D. Andrews R. (2013) Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 1: CD000422–CD000422.
55. Myint P. Kamath A. Vowler S. Maisey D. Harrison B. (2006) Severity assessment criteria recommended by the British Thoracic Society (BTS) for community-acquired pneumonia (CAP) and older patients. Should SOAR (systolic blood pressure, oxygenation, age and respiratory rate) criteria be used in older people? A compilation study of two prospective cohorts. Age Ageing 35: 286–291.
56. Naito T. Suda T. Yasuda K. Yamada T. Todate A. Tsuchiya T. et al (2006) A validation and potential modification of the pneumonia severity index in elderly patients with community-acquired pneumonia. J Am Geriatr Soc 54: 1212–1219.
57. Neupane B. Walter S. Krueger P. Marrie T. Loeb M. (2010) Predictors of inhospital mortality and re-hospitalization in older adults with community-acquired pneumonia: a prospective cohort study. BMC Geriatr 10: 22–23.
58. Nichol K. Nordin J. Mullooly J. Lask R. Fillbrandt K. Iwane M. (2003) Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 348: 1322–1332.
59. Niederman M. (1994) Empirical therapy of community-acquired pneumonia. Semin Respir Infect 9: 192–198.
60. Niederman M. McCombs J. Unger A. Kumar A. Popovian R. (1998) The cost of treating community-acquired pneumonia. Clin Ther 20: 820–837.
61. Ochoa-Gondar O. Vila-Córcoles A. de Diego C. Arija V. Maxenchs M. Grive M. et al (2008) The burden of community-acquired pneumonia in the elderly: the Spanish EVAN-65 study. BMC Public Health 8: 222–223.
62. Ochoa Gondar O. Vila Córcoles A. Rodriguez Blanco T. de Diego Cabanes C. Salsench Serrano E. Hospital Guardiola I. (2013) Ability of the modified CRB 75 severity scale in assessing elderly patients with community acquired pneumonia. Aten Primaria 45: 208–215.
63. Oshitani Y. Nagai H. Matsui H. (2013) Rationale for physicians to propose do-not-resuscitate orders in elderly community-acquired pneumonia cases. Geriatr Gerontol Int. DOI: 10.1111/ggi.12054.
64. Polverino E. Dambrava P. Cillóniz C. Balasso V. Marcos M. Esquinas C. et al (2010) Nursing home-acquired pneumonia: a 10 year single-centre experience. Thorax 65: 354–359.
65. Rello J. Rodriguez R. Jubert P. Alvarez B. (1996) Severe community-acquired pneumonia in the elderly: epidemiology and prognosis. Study Group for Severe Community-Acquired Pneumonia. Clin Infect Dis 23: 723–728.
66. Renshaw M. Rockwell J. Engleman C. Gewirtz A. Katz J. Sambhara S. (2002) Cutting edge: impaired Toll-like receptor expression and function in aging. J Immunol 169: 4697–4701.
67. Riquelme R. Torres A. El-Ebiary M. de la Bellacasa J. Estruch R. Mensa J. et al (1996) Community-acquired pneumonia in the elderly: a multivariate analysis of risk and prognostic factors. Am J Respir Crit Care Med 154: 1450–1455.
68. Riquelme R. Torres A. el-Ebiary M. Mensa J. Estruch R. Ruiz M. et al (1997) Community-acquired pneumonia in the elderly. Clinical and nutritional aspects. Am J Respir Crit Care Med 156: 1908–1914.
69. Skull S. Andrews R. Byrnes G. Campbell D. Kelly H. Brown G. et al (2009) Hospitalized community-acquired pneumonia in the elderly: an Australian case-cohort study. Epidemiol Infect 137: 194–202.
70. Teramoto S. Fukuchi Y. Sasaki H. Sato K. Sekizawa K. Matsuse T. (2008) High incidence of aspiration pneumonia in community- and hospital-acquired pneumonia in hospitalized patients: a multicenter, prospective study in Japan. J Am Geriatr Soc 56: 577–579.
71. Thiem U. Heppner H. Pientka L. (2011) Elderly patients with community-acquired pneumonia: optimal treatment strategies. Drugs Aging 28: 519–537.
72. Thiem U. Niklaus D. Sehlhoff B. Stückle C. Heppner H. Endres H. et al (2009) C-reactive protein, severity of pneumonia and mortality in elderly, hospitalised patients with community-acquired pneumonia. Age Ageing 38: 693–697.
73. Tracy J. Logemann J. Kahrilas P. Jacob P. Kobara M. Krugler C. (1989) Preliminary observations on the effects of age on oropharyngeal deglutition. Dysphagia 4: 90–94.
74. Trifirò G. Gambassi G. Sen E. Caputi A. Bagnardi V. Brea J. et al (2010) Association of community-acquired pneumonia with antipsychotic drug use in elderly patients: a nested case-control study. Ann Intern Med 152: 418–425, W139-W140.
75. Vecchiarino P. Bohannon R. Ferullo J. Maljanian R. (2004) Short-term outcomes and their predictors for patients hospitalized with community-acquired pneumonia. Heart Lung 33: 301–307.
76. Viasus D. Cordero E. Rodríguez-Baño J. Oteo J. Fernández-Navarro A. Ortega L. et al (2012) Changes in epidemiology, clinical features and severity of influenza A (H1N1) 2009 pneumonia in the first post-pandemic influenza season. Clin Microbiol Infect 18: E55–E62.
77. Viasus D. Paño-Pardo J. Pachón J. Campins A. López-Medrano F. Villoslada A. et al (2011) Factors associated with severe disease in hospitalized adults with pandemic (H1N1) 2009 in Spain. Clin Microbiol Infect 17: 738–746.
78. Vila Córcoles A. Ochoa Gondar O. Rodríguez Blanco T. (2010) Usefulness of the CRB-65 scale for prognosis assessment of patients 65 years or older with community-acquired pneumonia. Med Clin (Barc) 135: 97–102.
79. Vila-Corcoles A. Ochoa-Gondar O. Rodriguez-Blanco T. Raga-Luria X. Gomez-Bertomeu F. (2009) Epidemiology of community-acquired pneumonia in older adults: a population-based study. Respir Med 103: 309–316.
80. Woo J. Ho S. Mak Y. Law L. Cheung A. (1994) Nutritional status of elderly patients during recovery from chest infection and the role of nutritional supplementation assessed by a prospective randomized single-blind trial. Age Ageing 23: 40–48.
81. Woodhead M. Blasi F. Ewig S. Garau J. Huchon G. Ieven M. et al (2011) Guidelines for the management of adult lower respiratory tract infections - full version. Clin Microbiol Infect 17(Suppl. 6): E1–E59.
82. Zalacain R. Torres A. Celis R. Blanquer J. Aspa J. Esteban L. et al (2003) Community-acquired pneumonia in the elderly: Spanish multicentre study. Eur Respir J 21: 294–302.